Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology
Disease Category: Alzheimer's Disease
Trial Information
New treatment aimed at slowing down the progression of Alzheimer’s disease
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Efficacy and Safety Trial of Bapineuzumab in Patients with Mild to Moderate Alzheimer’s Disease
This two-year study is evaluating the safety and efficacy of an investigational medication as add-on treatment for patients with Alzheimer’s disease.
Major Inclusion/Exclusion Criteria:
- Ages 50-88
- Mild to moderate disease
- Must be living at home with caregiver
- Pacemakers, or any metal fragments in the body that would contradict a brain MRI are exclusionary
Alpine Clinical Research Center
1000 Alpine Avenue, Suite 200
Boulder, CO 80304
Phone: 303-443-7229 x105
EMail: pam@alpineresearch.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
